標(biāo)題: Titlebook: Cardiac Valve Replacement; Current Status Jack M. Matloff Book 1985 Springer Science+Business Media Dordrecht 1985 atherosclerosis.embolism [打印本頁(yè)] 作者: GERD847 時(shí)間: 2025-3-21 19:12
書目名稱Cardiac Valve Replacement影響因子(影響力)
作者: fluffy 時(shí)間: 2025-3-21 23:37
Thromboembolism after Cardiac Valve Replacementticoagulation morbidity associated with prosthetic valves and the long-term durability problems of bioprostheses. After the development of the STARR-EDWARDS. ball valve, which was hemodynamically quite sound, bioprosthetic valves were developed because these valves allegedly did not require anticoag作者: Chronological 時(shí)間: 2025-3-22 03:28
Nonprosthetic Factors Producing Thromboembolism in Patients with Cardiac Valve Substitutes: Their Nas mechanism and function, the operation itself and alterations during the follow-up period [2]. This chapter concerns the factors that contribute to thromboembolism in patients with cardiac valvular disease regardless of which prosthesis is used.作者: Onerous 時(shí)間: 2025-3-22 08:15
Reoperation after Cardiac Valve Surgery: Elective, Urgent and Emergent related complications associated with mechanical prostheses. Use of bioprostheses appears to have reduced thromboembolic complications, but unfortunately, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoper作者: 拍下盜公款 時(shí)間: 2025-3-22 10:36
Overview of Experience with the BJ?RK-SHILEY? Valvesubstitutes. The tilting disc mechanism was a considerable departure from the types of prosthetic devices in use at that time. The low profile and improved hemodynamic properties made the device especially attractive so that it rapidly became very popular and widely utilized for cardiac valve replac作者: 哭得清醒了 時(shí)間: 2025-3-22 16:31 作者: 哭得清醒了 時(shí)間: 2025-3-22 17:33
Aortic Valve Replacement with the IONESCU-SHILEY? Bovine Pericardial Valve: An 81 Month Experienceo initiate the routine use of this valve in the aortic position shortly after it became commercially available. Between February 1977 and December 1983, 240 patients underwent aortic valve replacement with an IONESCU-SHILEY valve. Concomitant procedures were performed in 110 patients (45.8%). Hospit作者: 無(wú)法破譯 時(shí)間: 2025-3-22 23:11
Annuloaortic Ectasia: Surgical Repair Using a Composite ST. JUDE MEDICAL? Valve and DACRON? Tube Grand ascending aorta with aortic regurgitation. The disease has proven to be much more prevalent than previously thought. The enlarged anulus on angiography has the appearance of a Florence flask (as used in the chemistry laboratory). In some instances, the annuloaortic ectasia is confined to the prox作者: 燒瓶 時(shí)間: 2025-3-23 03:20 作者: condescend 時(shí)間: 2025-3-23 06:18 作者: 脫落 時(shí)間: 2025-3-23 13:23 作者: foodstuff 時(shí)間: 2025-3-23 14:24
Vittorio Degiorgio,Ilaria CristianiThe STARR-EDWARDS. valve is associated with the birth of prosthetic valve surgery. Although it was not the first successful valve to be implanted in the anatomical position, it was the first prosthetic valve to gain universal acceptance.作者: inquisitive 時(shí)間: 2025-3-23 19:10
https://doi.org/10.1007/978-3-030-12558-5The need for tricuspid valve surgery remains a difficult problem for the cardiac surgeon. Conservative repair is always preferable in the treatment of tricuspid valve disease, but tricuspid valve replacement (TVR) is a necessity in some cases.作者: invert 時(shí)間: 2025-3-23 22:19
Regulation Without RepresentationThis chapter will address the question: Does the presence of coronary atherosclerosis (CAD) affect the outcome of valvular replacement surgery, and if so, how and why?作者: Commonplace 時(shí)間: 2025-3-24 03:45 作者: 思想靈活 時(shí)間: 2025-3-24 07:06 作者: 極大的痛苦 時(shí)間: 2025-3-24 11:36 作者: Aqueous-Humor 時(shí)間: 2025-3-24 16:06 作者: 匯總 時(shí)間: 2025-3-24 21:27 作者: Observe 時(shí)間: 2025-3-25 00:22 作者: 祖?zhèn)髫?cái)產(chǎn) 時(shí)間: 2025-3-25 03:47 作者: 輕信 時(shí)間: 2025-3-25 09:08 作者: ARM 時(shí)間: 2025-3-25 14:22 作者: 脫落 時(shí)間: 2025-3-25 16:42
Double Valve Replacement possibility of early and late valve-related complications and is usually performed in the setting of the myocardial dysfunction of chronic multivalvular heart disease. The entire experience with 121 patients undergoing double valve replacement (DVR) at Cedars-Sinai Medical Center between 1969 and 1982 forms the basis of this report.作者: Acquired 時(shí)間: 2025-3-25 23:25 作者: macabre 時(shí)間: 2025-3-26 01:02 作者: STING 時(shí)間: 2025-3-26 07:26 作者: Enzyme 時(shí)間: 2025-3-26 08:50 作者: arthroscopy 時(shí)間: 2025-3-26 16:09
Notebooks of Srinivasa Ramanujan,substitutes. The tilting disc mechanism was a considerable departure from the types of prosthetic devices in use at that time. The low profile and improved hemodynamic properties made the device especially attractive so that it rapidly became very popular and widely utilized for cardiac valve replac作者: perpetual 時(shí)間: 2025-3-26 19:20
Thomas Gaens,Volker Müller-Benedicts Hospital in Vancouver, Canada. From 1975 to May 1984 porcine bioprostheses were implanted in 2066 patients (99%) and mechanical prostheses, in 23 patients (1.0%), the majority being ST. JUDE MEDICAL. (SJM) valves.作者: Directed 時(shí)間: 2025-3-27 01:00
Thomas Gaens,Volker Müller-Benedicto initiate the routine use of this valve in the aortic position shortly after it became commercially available. Between February 1977 and December 1983, 240 patients underwent aortic valve replacement with an IONESCU-SHILEY valve. Concomitant procedures were performed in 110 patients (45.8%). Hospit作者: 哀悼 時(shí)間: 2025-3-27 04:57 作者: 你敢命令 時(shí)間: 2025-3-27 05:42
Exponential Diophantine Equations valve replacements. Operative mortality for the entire group of patients was 6.6%. Patients were divided into three groups: Group I = < 60 years of age, Group II = 60 to 69 years and Group III = 70+ years. Operative mortality for each group was: Group I = 5%, Group II = 5% and Group III = 11.5%. La作者: PLIC 時(shí)間: 2025-3-27 09:49
Computational Arithmetic of Modular Forms possibility of early and late valve-related complications and is usually performed in the setting of the myocardial dysfunction of chronic multivalvular heart disease. The entire experience with 121 patients undergoing double valve replacement (DVR) at Cedars-Sinai Medical Center between 1969 and 1作者: GULF 時(shí)間: 2025-3-27 16:45 作者: prediabetes 時(shí)間: 2025-3-27 21:11
https://doi.org/10.1007/978-88-470-1965-2s mechanism and function, the operation itself and alterations during the follow-up period [2]. This chapter concerns the factors that contribute to thromboembolism in patients with cardiac valvular disease regardless of which prosthesis is used.作者: obviate 時(shí)間: 2025-3-27 22:58
Thomas Gaens,Volker Müller-Benedicts Hospital in Vancouver, Canada. From 1975 to May 1984 porcine bioprostheses were implanted in 2066 patients (99%) and mechanical prostheses, in 23 patients (1.0%), the majority being ST. JUDE MEDICAL. (SJM) valves.作者: 愛哭 時(shí)間: 2025-3-28 05:15 作者: jovial 時(shí)間: 2025-3-28 09:28 作者: pericardium 時(shí)間: 2025-3-28 13:48 作者: 異端邪說(shuō)2 時(shí)間: 2025-3-28 15:17 作者: 描繪 時(shí)間: 2025-3-28 20:35 作者: Transfusion 時(shí)間: 2025-3-29 00:35 作者: 平息 時(shí)間: 2025-3-29 05:09
Book 1985neric cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair [2]. Thus, these proceed- ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve r作者: oxidize 時(shí)間: 2025-3-29 08:24
a more generic cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair [2]. Thus, these proceed- ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve r978-1-4612-9629-4978-1-4613-2601-4作者: CRUMB 時(shí)間: 2025-3-29 14:47 作者: expound 時(shí)間: 2025-3-29 16:36
st three symposia on this topic were held primarily for designated investigators involved in clinical trials of the ST. JUDE MEDICAL valve. The last meeting, chaired by Michael E. DeBakey, M.D., was held in November 1982 [1], immediately before the valve was released for general clinical use in the 作者: GREEN 時(shí)間: 2025-3-29 21:27 作者: harbinger 時(shí)間: 2025-3-30 01:09
Vittorio Degiorgio,Ilaria Cristianitely, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoperation for valve replacement when weighing the potential benefits of a bioprosthesis. This chapter assesses the risks of valve reoperation and its effect on subsequent longevity.作者: Nausea 時(shí)間: 2025-3-30 05:26 作者: 潛伏期 時(shí)間: 2025-3-30 12:00 作者: fluoroscopy 時(shí)間: 2025-3-30 14:26 作者: 靦腆 時(shí)間: 2025-3-30 19:39
